awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36270034-064D3CCF-514C-4FAE-8A74-B70A1F53D7DE
Q36270034-064D3CCF-514C-4FAE-8A74-B70A1F53D7DE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36270034-064D3CCF-514C-4FAE-8A74-B70A1F53D7DE
Acute vascular response to cediranib treatment in human non-small-cell lung cancer xenografts with different tumour stromal architecture.
P2860
Q36270034-064D3CCF-514C-4FAE-8A74-B70A1F53D7DE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36270034-064D3CCF-514C-4FAE-8A74-B70A1F53D7DE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bf3f7e7df2ae88207e7100843a06ebb43479cc7e
P2860
AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer